Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice. (Q50514234)
Jump to navigation
Jump to search
scientific article published on 16 August 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice. |
scientific article published on 16 August 2011 |
Statements
1 reference
Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice. (English)
1 reference
1 reference
1 reference
Amanda Nordigården
1 reference
Jenny Zetterblad
1 reference
Cecilia Trinks
1 reference
Pernilla Eliasson
1 reference
Pia Druid
1 reference
Kourosh Lotfi
1 reference
Thomas M Walz
1 reference
16 August 2011
1 reference
155
1 reference
2
1 reference
198-208
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference